| Literature DB >> 33927629 |
Halina Ekiert1, Joanna Świątkowska1, Ewa Knut1, Paweł Klin2, Agnieszka Rzepiela3, Michał Tomczyk4, Agnieszka Szopa1.
Abstract
Artemisia dracunculus L. (tarragon), Asteraceae, is a species that has long been used in traditional Asian medicine, mainly in Iran, Pakistan, Azerbaijan and India. It is known as a spice species in Asia, Europe and the Americas. The raw materials obtained from this species are herb and leaf. The presence of essential oil with a highly variable composition, as well as flavonoids, phenolic acids, coumarins and alkamides, determines the medicinal and/or spice properties of the plant. In traditional Asian medicine, this species is used, for example, in the treatment of digestive system diseases, as an analgesic, hypnotic, antiepileptic, anti-inflammatory and antipyretic agent, and as an effective remedy in the treatment of helminthiasis. Nowadays, A. dracunculus is the subject of professional phytochemical and pharmacological researches. Pharmacological studies have confirmed its anti-inflammatory and analgesic effects known from traditional uses; they have also proved very important new findings regarding its biological activity, such as antioxidant, immunomodulating and anti-tumour activities, as well as hepatoprotective and hypoglycaemic effects. A. dracunculus has long-held an established position in the food industry as a spice. And its use is growing in the cosmetics industry. Moreover, it is the subject of biotechnological research focused mainly on the development of micro-propagation protocols.Entities:
Keywords: biological activity; biotechnological studies; chemical composition; position in cosmetology; potential medicinal value; tarragon; traditional medicine use
Year: 2021 PMID: 33927629 PMCID: PMC8076785 DOI: 10.3389/fphar.2021.653993
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1Chemical structure of volatile compounds characteristic of the essential oil of the A. dracunculus herb.
Chemical composition of A. dracunculus essential oil.
| Compounds | References |
|---|---|
| Phenylpropane derivatives | |
| Estragole (methylchavicol, |
|
| Methyl eugenol |
|
| Elemicin |
|
| Isoelemycin |
|
| Eugenol |
|
| Isoeugenol methyl ether |
|
| Asarone, isoeugenol methyl |
|
| ( |
|
| Prestragol |
|
| Anethole, carpacin |
|
| Dillapiole |
|
| 3-( |
|
| Monoterpenoids | |
| Sabinene |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| 4-Terpineol |
|
| Terpinolene |
|
| |
|
| Linalool |
|
| Limonene |
|
| |
|
| |
|
| |
|
| |
|
| Citronellol |
|
| Citronellol acetate, neryl acetate |
|
| Citronellol formate, terpineol, |
|
| ( |
|
| |
|
| |
|
| 4-Carene, |
|
| Carvone |
|
| Myrcene |
|
| Phellandrene |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| Camphene |
|
| |
|
| |
|
| |
|
| Thymol |
|
| |
|
| 1,8-Cineol, isoterpinolene, artemisinic ketone, isobornyl acetate, pseudolimonene |
|
| 2- |
|
| ∆3-carene |
|
| Borneol, |
|
| |
|
| Bornyl acetate |
|
| Geraniol, |
|
| Myrtenal, pinocarveol |
|
| Carvacrol, |
|
| Sesquiterpenoids | |
| Spatulenol |
|
| Spathunelol |
|
| |
|
| Germacrene-D-4-ol, |
|
| Germacrene D |
|
| Farnesane |
|
| ar-Curcumen, caryophyllene oxide, |
|
| |
|
| |
|
| Caryophyllene |
|
| |
|
| Elemene |
|
| |
|
| bicyclermacren, |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| Diterpenoids | |
| Phytol |
|
| Triterpenoids | |
| Squalene |
|
| Polyacetylenes | |
| Capillene |
|
| 1-Phenyl-2,4-hexadiene, 1-phenyl-2,4-hexadiene-1-one |
|
| Isocoumarins | |
| 3-(1 |
|
| Other compounds | |
| Dehydro-1,8-cineole, myrysticin |
|
| Apiole |
|
| Acenaphthene |
|
| 3-Methoxycinnamaldehyde, |
|
| 5-Phenyl-1,3-pentadiyne |
|
| Hexanal |
|
| 1,3-Oktadiene, methyl salicylate, 1-pentadecene |
|
FIGURE 2Chemical structure of herniarin–compound characteristic for the A. dracunculus herb.
Chemical composition of A. dracunculus.
| Group of compounds | Compounds | References |
|---|---|---|
| Flavonoids | 2′,4′-Dihydroxy-4-methoxydihydrochalcone syn. DMC-2; 4-O-methyldavidigenin |
|
| Quercetin |
| |
| Kaempferol |
| |
| Luteolin |
| |
| Apigenin |
| |
| Pinocembrin |
| |
| Naringenin |
| |
| 3,5,4-Trihydroxy-7,3′-dimethoxyflavone, |
| |
| 3,5,4′-trihydroxy-7-methoxyflavone, | ||
| 5,6,7,8,4′-pentahydroxymetoflavone, | ||
| 5,7-dihydroxy flavone, | ||
| 7- | ||
| 5,7-dihydroxflavone, | ||
| 7- | ||
| Davidigenin |
| |
| Sacuranetine | ||
| Rutoside |
| |
| Quercetin 3- |
| |
| Isoquercitrin |
| |
| Patuletin 3- | ||
| Patuletin hexoside | ||
| Patuletin rhamnosylhexoside | ||
| Patuletin malonylrhamnosylhexoside | ||
| Vicenin | ||
| 7,3′-Dimethyleriodictyol |
| |
| 7-Methyleriodictyol | ||
| 7-Methylaringenine | ||
| Biocovertsetin |
| |
| Hyperoside | ||
| Rutoside | ||
| Estroside |
| |
| Kaempferol glycosides | ||
| Quercetin glycosides | ||
| Luteolin glycosides | ||
| Isorhamnetin glycosides |
| |
| Coumarins | Herniarin |
|
| 3,4-Dehydroherniarin, skimmin, |
| |
| (-)-( |
| |
| (+)-( | ||
| (+)-( | ||
| 4-hydroxycoumarin, | ||
| 7,8-methylenedioxy-6-methoxycoumarin, | ||
| 8-hydroksyartemidin artemidiol artemidynal ether, | ||
| 7-methyl daphnetin ether methylenedaphnetin, | ||
| isovalerate capillarin, | ||
| γ,γ-dimethylallyl ether esculetin | ||
| 6-Demethoxycapilarisine |
| |
| Dacumerin |
| |
| Scoparon | ||
| Scopoletin |
| |
| Arethinol |
| |
| Aridiodiol | ||
| Artidin | ||
| Isocoumarin | ||
| 9-Hydroxyartemidine, esculetin |
| |
| 8-Hydroxycapillarin, artemidinol |
| |
| Esculin | ||
| Capillarin | ||
| Artemidine |
| |
| Coumarin |
| |
| Phenolic acids | ( |
|
| 4,5-di- | ||
| 5- | ||
| 3,5- | ||
| 4,5-di- |
| |
| 5- | ||
| Ferulic acid hexoside |
| |
| Caffeoylquinic acid, sakuranetin |
| |
| Chicory acid |
| |
| Caffeic acid, chlorogenic acid |
| |
|
|
| |
| Ferulic acid, syringic acid |
| |
| Vanillic acid |
| |
| 2-Methoxycinnamic acid |
| |
| Alkamides | Neopelitorin A, neopelitorin B, pelitoryin |
|
| Sterols | Stigmasterol |
|
| Fatty acids | Myristic acid, oleic acid, palmitic acid |
|
| Vitamins | Vitamin C |
|
| Minerals | Iodine compounds |
|
| Enzymes | Peroxidases |
|
| Tannins | No data |
|
| Other compounds | 1-Methoxy-4-(2-propenyl) benzene, 3,7-dimethyl-1,3,7-octatriene |
|
| 4-(1′,1′,2′,2′-Tetramethylpropyl)-1,2-benzenediol |
| |
| Phytoalexin |
| |
| Benzyl benzoate, methyl salicylate, trimethoxyallylbenzene |
| |
| 1,9,2-Octalone, 7-methoxy-1-indanone, cinnamic aldehyde, simetyloacetal, ociminon acetate, 3- methylbenzyl |
| |
| Anisaldehyde |
| |
|
|
| |
| Cuminic aldehyde, 2(3H)-furanone,5-hexyldihydro-benzen, ethanol, α-2-propenyl-methyl cinnamate |
| |
|
| ||
| (2 |
|
Pharmacological properties of A. dracunculus.
| Activity | Mechanism of action | References |
|---|---|---|
| Anti-bacterial and anti-fungal | Inhibition of the growth of |
|
|
|
| |
| essential oil of |
| |
|
|
| |
| hydro-ethanolic extract of |
| |
| Inhibition of the growth of bacteria: |
| |
| Inhibition of the growth of bacteria: |
| |
| Anti-protozoal | Inhibition of the development of the promastigote form of |
|
| Antioxidant | Reducing properties of the hydro-ethanolic herbal extract related to the presence of phenolic compounds and flavonoids |
|
| Reduction of DPPH and ABTS in the presence of phenolic compounds |
| |
| Anti-inflammatory and analgesic | Reduction of pain sensations and reduction of xylene-induced ear edema after administration of the ethanolic herbal extract to mice |
|
| Inhibition of ROS, IL-8 and TNF-α production in imitated inflammation |
| |
| Immuno-modulating | Reduction in IL-17 and IFN-γ production and intensification of the phagocytosis process carried out by macrophages |
|
| Lowering of IL-17 and IL-23 levels and reduces the infiltration of leukocytes into brain cells |
| |
| Increased neutrophil levels and decreased lymphocyte levels after intraperitoneal administration of the hydro-ethanolic extract from the leaves |
| |
| Anti-depressive | Increased resistance to stressful situations and reduction of stress-related levels of inflammatory cytokines |
|
| The phenolic compounds and flavonoids contained in the |
| |
| Mild inhibition of hMAO-A and hMAO-B by extracts of |
| |
| Anti-tumor | Inhibition of proliferation of mouse lymphoma cells (L5178YD) due to the presence of polyphenols and alkamides in leaf extracts |
|
| Hepato-protective | Decrease in levels of alanine transaminase, aspartate transaminase, alkaline phosphatase and total bilirubin, and increase in total protein levels |
|
| Hypo-glycaemic | Decrease in glycated hemoglobin, decrease in area under curve for insulin, decrease in total insulin secretion, decrease in systolic blood pressure, and increase in HDL-C |
|
| Normalizing the profile of thyroid hormones | Increase in thyroxine and triiodothyronine levels, decrease in elevated levels of thyrotropin, and increase in total antioxidant capacity, increase in glutathione, and decrease in malondialdehyde levels |
|
| Inhibiting the activity of carbonic anhydrase I and II | Compounds contained in herbal extracts reduce the activity of carbonic anhydrase I and II. |
|
| Repelling insects | Inhibition of |
|
| Larvacidal effect against |
|
Applications of A. dracunculus in cosmetology as recommended by the CosIng database.
| Name according to CosIng | Description | Application profile |
|---|---|---|
|
| Flowers of the tarragon plant | Skin care agent |
|
| Extract from tarragon herb | Fragrance |
|
| Extract from tarragon leaves and stems | Masking agent |
|
| Essential oil of tarragon | Fragrance, skin care agent |
|
| Extract from tarragon roots | Skin care agent |
|
| Extract from tarragon seeds, roman chamomile seeds, and tutsan (shrubby st. John’s wort) seeds | Skin care agent |